Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Minggu Fen (明骨粉) is a health food supplement developed and manufactured by Jilin Fukang Pharmaceutical. It is marketed in the form of oral capsules (Minggu Fen Jiaonang) and is primarily used for bone health support. The product consists of bone powder, likely derived from animal sources such as deer or cattle, which provides a natural source of calcium, phosphorus, and other minerals essential for maintaining bone density. In China, it is classified as a 'health food' (保健食品) rather than a pharmaceutical drug, meaning it is intended for health maintenance and the reduction of disease risk factors rather than the treatment of acute conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Minggu Fen.